A new study from researchers at Brigham Young University finds that alcohol-free hand sanitizer is just as effective at disinfecting surfaces from the COVID-19 virus as alcohol-based products. In most of the test cases, the compounds found in alcohol-free sanitizers wiped out at least 99.9% of the virus within 15 seconds.
Story tips from Johns Hopkins experts on Covid-19.
A team of zoologists and microbiologists from NUI Galway have published a new study showing that common house spiders carry bacteria susceptible to infect people, with the Noble False Widow spiders also carrying harmful strains resistant to common antibiotic treatments.
New insight on how a parasite can resist current therapies has been published today in the open-access eLife journal.
DOAC (direct oral anticoagulant) pills are used in the treatment of atrial fibrillation by preventing blood clots. Even though blood clots are thought to contribute to complications from the new coronavirus infection, users of this class of drug do not seem to be protected against severe COVID-19, reports a large Swedish registry study from Karolinska Institutet published in The Journal of Internal Medicine.
KU Leuven researchers published results of their vaccine candidate, a vector vaccine based on the yellow fever vaccine. The paper shows that the vaccine protects hamsters from infection with the SARS-CoV-2 coronavirus after a single dose. It is also effective in monkeys.
The role of a protein in detecting the common cold virus and kickstarting an immune response to fight infection has been uncovered by a team of scientists from Nanyang Technological University, Singapore (NTU Singapore), the Agency for Science, Technology and Research (A*STAR) and the National University of Singapore.
A repurposed mouse model can develop symptoms of both severe COVID-19 (lung damage, blood clots, abnormal blood vessels, and death) and also of milder disease, including loss of the sense of smell, according to a recent University of Iowa study published in Nature.
A new device for faster testing of antibiotic-resistant bacteria has been developed by researchers at Binghamton University, State University of New York.
Curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined. However, the current diagnostic techniques vary in reliability and relevance, so an understanding of which test is most appropriate for a given circumstance is necessary to avoid false reports. Researchers evaluated the available diagnostic techniques and determined key steps required for better testing moving forward. They present their findings in the journal APL Bioengineering.